"The US Food and Drug Administration (FDA) today approved etanercept-szzs (Erelzi, Sandoz), a biosimilar to etanercept (Enbrel, Amgen) for rheumatoid arthritis and other inflammatory diseases.
The biosimilar to etaner"...
DEPO-MEDROL is contraindicated in patients with known hypersensitivity to the product and its constituents.
DEPO-MEDROL Sterile Aqueous Suspension is contraindicated for intrathecal administration. Reports of severe medical events have been associated with this route of administration.
DEPO-MEDROL is contraindicated in systemic fungal infections, except when administered as an intraarticular injection for localized joint conditions (see WARNINGS: Infections , Fungal Infections).This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 9/26/2016
Additional Depo Medrol Information
Depo Medrol - User Reviews
Depo Medrol User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get the latest treatment options